Chairman and Chief Executive Officer, Scholar Rock Holding Corporation
Search every verified David Hallal interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. David Hallal, chairman and chief executive officer of Scholar Rock Holding, discussed his career in biotechnology and the potential of cell and gene therapies in a February 2023 podcast appearance. At the time, he was CEO of ElevateBio, a company he co-founded in 2017 that provides tools and manufacturing capabilities for cell therapy developers. He described the 2017 FDA approvals of the first CD19-directed CAR-T therapies as a pivotal moment, stating he believed it was a matter of "when," not "if," cell and gene therapy would become a dominant treatment modality. He also noted that ElevateBio added more than ten new customers to its platform in 2022, including large biotech and pharmaceutical companies, and emphasized the importance of a long-term strategy to remain both scientifically and financially relevant in the field. Hallal also reflected on his earlier work at Amgen, where he contributed to the development of aflibercept (Eylea), a treatment for age-related macular degeneration, and credited Regeneron for overcoming skepticism about the drug's market potential. He spoke about his personal background, describing himself as the son of a barber and highlighting his parents as his heroes, with a particular focus on his mother's optimism.
David Hallal, Scholar Rock CEO, joins 'Fast Money' to talk its recent drug study results that found its drug taken in combination with Zepbound helped prevent muscle loss.
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.
David Hallal was the featured speaker and received an honorary Doctor of Humane Letters at the University of New Haven Spring 2016 Commencement Ceremony. Hallal is chief executive officer of Alexion, a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. He is also a member of the company’s board of directors. Read more at http://unhtoday.newhaven.edu/index.ph...
Sign in to search the full transcript archive, filter by topic, and access every quote from David Hallal.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans